Researchers

Results 61-79 of 79
Issue DateTitleAuthor(s)TypeМp-cat.
2007Application of the EIIP/ISM bioinformatics concept in development of new drugsVeljković, Veljko ; Veljković, Nevena V.  ; Este, J. A.; Huether, A.; Dietrich, U.Reviews
21aM21a
2006Development of a diagnostic immunoassay for the detection of natural anti-NTM/VIP antibodies of HIV-1Krikorian, D.; Zevgiti, S.; Veljković, Veljko ; Sakarellos-Daitsiotis, M.; Sakarellos, C.Conference Paper
Mp. category will be shown later
2006Development of diagnostics and vaccine candidates for the highly pathogenic H5N1 influenza virusZevgiti, S.; Krikorian, D.; Panou-Pomonis, E.; Veljković, Veljko ; Sakarellos-Daitsiotis, M.; Sakarellos, C.Conference Paper
Mp. category will be shown later
2006Theoretical stability assessment of uranyl phosphates and apatites: Selection of amendments for in situ remediation of uraniumRaičević, Slavica; Wright, JV; Veljković, Veljko ; Conca, JLArticle
21M21
2004Antibodies reactive with C-terminus of the second conserved region of HIV-1gp120 as possible prognostic marker and therapeutic agent for HIV diseaseVeljković, Nevena V.  ; Branch, DR; Metlaš, Radmila; Prljić, Jelena ; Manfredi, R; Stringer, WW; Veljković, Veljko Article
22M22
2004Localization of recognition site between transforming growth factor-beta(1) (TGF-beta(1)) and TGF beta receptor type II: possible implications in breast cancerIvanović, Vesna; Demajo, Miroslav ; Todorović-Raković, N  ; Nikolic-Vukosavljevic, D; Nešković-Konstantinović, Zora  ; Krtolica-Žikić, Koviljka; Veljković, Veljko ; Prljić, Jelena ; Dimitrijević, Bogomir B. Article
23M23
2004Application of VIP/NTM-reactive natural antibodies in therapy of HIV diseaseVeljković, Veljko ; Metlaš, RadmilaReviews
Mp. category will be shown later
2004Safety and ethical consideration of AIDS vaccineVeljković, Veljko ; Prljić, Jelena ; Veljković, TatjanaReviews
Mp. category will be shown later
2004Recombination property of the HIV-1 gp120 genePrljić, Jelena ; Veljković, Nevena V.  ; Veljković, Veljko Article
Mp. category will be shown later
2004Molecular makeup of HIV-1 envelope proteinVeljković, Veljko ; Veljković, Nevena V.  ; Metlaš, RadmilaReviews
Mp. category will be shown later
2004HIV-1 gp120 and immune networkMetlaš, Radmila; Veljković, Veljko Reviews
Mp. category will be shown later
2004AIDS vaccine: State of the art at the beginning of the third millenniumVeljković, Veljko ; Kohler, Heike; Muller, SReviews
Mp. category will be shown later
2003Design of peptide mimetics of HIV-1 gp120 for prevention and therapy of HIV diseaseVeljković, Nevena V.  ; Branch, DR; Metlaš, Radmila; Prljić, Jelena ; Vlahovicek, K; Pongor, S; Veljković, Veljko Article
22M22
2003Does VaxGen hide the breakthrough infections?Veljković, Veljko ; Muller, S; Kohler, HeikeContribution to periodical
21a+M21a+
2003AIDSVAX results: an important open questionVeljković, Veljko ; Muller, S; Kohler, HeikeArticle
21a+M21a+
2001AIDS epidemic at the beginning of the third millennium: time for a new AIDS vaccine strategyVeljković, Veljko ; Metlaš, Radmila; Kohler, Heike; Urnovitz, HB; Prljić, Jelena ; Veljković, Nevena V.  ; Johnson, E; Muller, SContribution to periodical
21a+M21a+
2001The role of passive immunization in HIV-positive patients - A case reportVeljković, Veljko ; Metlaš, Radmila; Jevtović, D.; Stringer, WWArticle
21M21
1999Identification of an active Chi recombinational hot spot within the HIV-1 envelope gene: consequences for development of AIDS vaccinesPrljić, Jelena ; Veljković, Nevena V.  ; Doliana, Roberto; Colombatti, Alfonso; Johnson, Emmett; Metlaš, Radmila; Veljković, Veljko Article
21a+M21a+
1997Molecular basis of the inefficacy and possible harmful effects of AIDS vaccine candidates based on HIV-1 envelope glycoprotein gp120Veljković, Veljko ; Johnson, E; Metlaš, RadmilaArticle
21a+M21a+